Table 2 Comparisons between nonsurvivors and survivors at 3 months after cardiac arrest
| Â | Total | Nonsurvivor | Survivor | P value |
|---|---|---|---|---|
N = 268 | N = 253 | N = 15 | ||
Age, median (IQR) | 85 (79–89) | 85 (80–89) | 78 (68–84) | 0.006 |
Men, n (%) | 144 (53.7%) | 136 (53.8%) | 8 (53.3%) | 1.00 |
Antipsychotic use, n (%) | 62 (23.1%) | 55 (21.7%) | 7 (46.7%) | 0.051 |
Dopamine agonists use, n (%) | 25 (9.3%) | 22 (8.7%) | 3 (20.0%) | 0.15 |
Anticholinergic agents use, n (%) | 42 (15.7%) | 37 (14.6%) | 5 (33.3%) | 0.067 |
Sedative agents use, n (%) | 80 (29.9%) | 75 (29.6%) | 5 (33.3%) | 0.78 |
Steroid use, n (%) | 13 (4.9%) | 12 (4.7%) | 1 (6.7%) | 0.54 |
Dementia (with donepezil use), n (%) | 38 (14.2%) | 36 (14.2%) | 2 (13.3%) | 1.00 |
Stroke, n (%) | 81 (30.2%) | 76 (30.0%) | 5 (33.3%) | 0.78 |
Sjogren’s syndrome, n (%) | 5 (1.9%) | 5 (2.0%) | 0 (0.0%) | 1.00 |
Daily life independence level, n (%) | ||||
 Unrated | 99 (36.9%) | 93 (36.8%) | 6 (40.0%) | 0.89 |
 Independence | 64 (23.9%) | 60 (23.7%) | 4 (26.7%) |  |
 Dependence | 105 (39.2%) | 100 (39.5%) | 5 (33.3%) |  |
Nursing home, n (%) | 15 (5.6%) | 15 (5.9%) | 0 (0.0%) | 1.00 |
State of dysphagia (within 12 months) | ||||
 Dysphagia rehabilitation, n (%) | 14 (5.2%) | 14 (5.5%) | 0 (0.0%) | 1.00 |
 Aspiration pneumonia, n (%) | 21 (7.8%) | 20 (7.9%) | 1 (6.7%) | 1.00 |